These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 1988120

  • 1. Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
    Dive C, Watson JV, Workman P.
    Cancer Res; 1991 Feb 01; 51(3):799-806. PubMed ID: 1988120
    [Abstract] [Full Text] [Related]

  • 2. Elevation of leukemic cell intracellular calcium by the ether lipid SRI 62-834.
    Lazenby CM, Thompson MG, Hickman JA.
    Cancer Res; 1990 Jun 01; 50(11):3327-30. PubMed ID: 2334926
    [Abstract] [Full Text] [Related]

  • 3. Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells.
    Workman P, Donaldson J, Lohmeyer M.
    Biochem Pharmacol; 1991 Jan 15; 41(2):319-22. PubMed ID: 1989642
    [No Abstract] [Full Text] [Related]

  • 4. Lack of enantio-selectivity in the in vitro antitumour cytotoxicity and membrane-damaging activity of ether lipid SRI 62-834: further evidence for a non-receptor-mediated mechanism of action.
    Lohmeyer M, Workman P.
    Biochem Pharmacol; 1992 Aug 18; 44(4):819-23. PubMed ID: 1510728
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA, Buettner GR, Oberley LW, Burns CP.
    Cancer Res; 1998 Jul 01; 58(13):2809-16. PubMed ID: 9661895
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin.
    Evans CH, Baker PD.
    Cancer Res; 1992 Nov 01; 52(21):5893-9. PubMed ID: 1356622
    [Abstract] [Full Text] [Related]

  • 10. Multiparameter flow cytometric analysis of a novel cytotoxin (factor 2) induced tumor cell membrane permeability.
    Ni J, Watson JV, Cox H, Karpas A.
    Cytometry; 1993 Nov 01; 14(3):281-6. PubMed ID: 8472604
    [Abstract] [Full Text] [Related]

  • 11. Platelet-activating factor (PAF) receptor-mediated calcium mobilization and phosphoinositide turnover in neurohybrid NG108-15 cells: studies with BN50739, a new PAF antagonist.
    Yue TL, Gleason MM, Gu JL, Lysko PG, Hallenbeck J, Feuerstein G.
    J Pharmacol Exp Ther; 1991 Apr 01; 257(1):374-81. PubMed ID: 1850473
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X, Ottino P, Bazan HE, Bazan NG.
    Invest Ophthalmol Vis Sci; 2004 Sep 01; 45(9):2915-21. PubMed ID: 15326102
    [Abstract] [Full Text] [Related]

  • 14. Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells.
    Cellai C, Laurenzana A, Vannucchi AM, Della Malva N, Bianchi L, Paoletti F.
    FASEB J; 2002 May 01; 16(7):733-5. PubMed ID: 11923217
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor activity of a piperidine phospholipid.
    Houlihan WJ, Lee ML, Munder PG, Handley DA, Nemecek GA, Jaeggi CS, Winslow CW.
    Arzneimittelforschung; 1994 Dec 01; 44(12):1384-8. PubMed ID: 7848363
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI, Gallegos A, Dressler LA, Modest EJ, Powis G.
    Cancer Res; 1993 Sep 15; 53(18):4297-302. PubMed ID: 8395981
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
    Morrison WJ, Shukla SD.
    J Pharmacol Exp Ther; 1989 Sep 15; 250(3):831-5. PubMed ID: 2550620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.